Expertise in
95
conditions

Min S. Zhou

State Key Laboratory Of Bioreactor Engineering, 
Shanghai, CN 
Expertise in
95
conditions
State Key Laboratory Of Bioreactor Engineering, 
Shanghai, CN 

Overview

Min Zhou practices practicing medicine in Shanghai, China.

Zhou is highly rated in 95 conditions, according to our data. Their clinical expertise encompasses Hypogonadism Primary Partial Alopecia, Thoracic Aortic Aneurysm, Pneumonia, Aneurysm Repair, and Vitrectomy.

They are actively involved in clinical research, co-authoring 2702 peer reviewed articles and participating in 3 clinical trials.

Locations

State Key Laboratory Of Bioreactor Engineering, Shanghai, 200237, China
Other Locations
No. 17, Lu Jiang Road, Hefei, 230001, China
No. 238, Jiefang Road, Wuhan, 430060, China
No.197 Ruijin 2nd Road, Shanghai, 200025, China
No. 103, Wenhua Road, Shenyang, 110016, China
No.200 Xiao Ling Wei Street, Nanjing, 210094, China
No. 1095 Jiefang Avenue, Wuhan, 430030, China
Xiang'an South Road, Xiamen, 361102, China
93 Ji Chuan Road, Taizhou, 225300, China
300 Xueshi Road, Changsha, 410208, China
197 Ruijin 2nd Road, Shanghai, 200025, China
Guangzhou International Bio Island, Guangzhou, China
13 Hangkong Rd, Wuhan, 430030, China
No. 100, Daxue East Road, Nanning, 530004, China
321 Zhongshan Road, Nanjing, 210008, China
18 Daoshan Road, Fuzhou, 350001, China
Union Hospital, Wuhan, 430022, China
No. 200 Xiaolingwei Street, Nanjing, 210094, China
Yiheyuan Street. 5, Beijing, 100871, China
79 Qingchun Road, Hangzhou, 310003, China
Jiefang West Road 61, Changsha, 410002, China
143 North Road, Qilihe, 730050, China
180 Fenglin Road, Shanghai, 200032, China
66 Chongshan Middle Road, Shenyang, 110036, China
No.1095 Jie Fang Avenue, Wuhan, 430030, China
238 Jiefang Road, Wuhan, 430060, China
51 Fucheng Road, Beijing, 100048, China
No. 169, Donghu Rd, Wuhan, China
Middle Yanchang Road 399, Shanghai, 200072, China
No. 87 Xiangya Road, Changsha, 410008, China
83 Fenyang Rd, Shanghai, China
321 Hankou Road, Nanjing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Open-label, Multicenter Study of the Efficacy and Safety of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) Harboring a HER2 Exon 20 Mutation Who Progressed on or After Treatment With Platinum Based Chemotherapy
A Phase 3, Randomized, Open-label, Multicenter Study of the Efficacy and Safety of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) Harboring a HER2 Exon 20 Mutation Who Progressed on or After Treatment With Platinum Based Chemotherapy
Enrollment Status: Completed
Publish Date: December 19, 2025
Intervention Type: Drug
Study Drugs: Pyrotinib, Docetaxel
Study Phase: Phase 3
A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of R-GemOx Regimen as First-line Treatment in Elderly Patients With Diffuse Large B-cell Lymphoma (DLBCL).
A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of R-GemOx Regimen as First-line Treatment in Elderly Patients With Diffuse Large B-cell Lymphoma (DLBCL).
Enrollment Status: Unknown
Publish Date: February 15, 2019
Intervention Type: Drug
Study Drug: R-GemOx
Study Phase: Phase 2
A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of DA-EPOCH Regimen for Non-Hodgkin's Lymphoma With Hemophagocytic Lymphohistiocytosis
A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of DA-EPOCH Regimen for Non-Hodgkin's Lymphoma With Hemophagocytic Lymphohistiocytosis
Enrollment Status: Unknown
Publish Date: February 15, 2019
Intervention Type: Drug
Study Drug: DA-EPOCH
Study Phase: Phase 2
View 2 Less Clinical Trials

2700 Total Publications

The Lark-Loop Technique for Onlay Biceps Tenodesis: A Biomechanical, Histological, and Radiological Study in a Rabbit Model.
The Lark-Loop Technique for Onlay Biceps Tenodesis: A Biomechanical, Histological, and Radiological Study in a Rabbit Model.
Journal: The American journal of sports medicine
Published: September 05, 2026

Frequently Asked Questions about Min S. Zhou

Is Min S. Zhou a top-rated expert for Hypogonadism Primary Partial Alopecia?

MediFind is an objective health platform that identifies experts based on real-world data. Min S. Zhou is classified as an Distinguished expert for Hypogonadism Primary Partial Alopecia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Min S. Zhou participate in research or clinical trials?

Yes. Min S. Zhou has published 2700 articles and abstracts on conditions like Hypogonadism Primary Partial Alopecia. You can view a list of Min S. Zhou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhou's expertise for a condition
ConditionClose
    View All 13 Distinguished Conditions
    View All 82 Advanced Conditions
    View All 280 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile